These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M. Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857 [Abstract] [Full Text] [Related]
6. Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis. Amoli MM, Gonzalez-Gay MA, Zeggini E, Salway F, Garcia-Porrua C, Ollier WE. J Rheumatol; 2004 Dec; 31(12):2413-7. PubMed ID: 15570643 [Abstract] [Full Text] [Related]
7. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia. Wu JS, Qiu W, Castley A, James I, Mastaglia FL, Christiansen FT, Carroll WM, Joseph J, Kermode AG. Mult Scler; 2010 Jan; 16(1):15-20. PubMed ID: 19995849 [Abstract] [Full Text] [Related]
8. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis. Sayad A. Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928 [Abstract] [Full Text] [Related]
13. [The study on relation of HLA-DRB1 gene polymorphism to Keshan disease and its association and linkage in the core families]. Wei J, Niu XL, Dong X, Wang YP, Zhu JH. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb 15; 24(1):91-3. PubMed ID: 17285554 [Abstract] [Full Text] [Related]
15. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients. Cejkova P, Novota P, Cerna M, Kolostova K, Novakova D, Kucera P, Novak J, Andel M, Weber P, Zdarsky E. Int J Immunogenet; 2008 Apr 15; 35(2):133-40. PubMed ID: 18279373 [Abstract] [Full Text] [Related]
16. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis. Ramagopalan SV, Byrnes JK, Dyment DA, Guimond C, Handunnetthi L, Disanto G, Yee IM, Ebers GC, Sadovnick AD. J Hum Genet; 2009 Sep 15; 54(9):547-9. PubMed ID: 19629136 [Abstract] [Full Text] [Related]
17. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis. Yousefipour G, Erfani N, Momtahan M, Moghaddasi H, Ghaderi A. Acta Neurol Scand; 2009 Dec 15; 120(6):424-9. PubMed ID: 19737153 [Abstract] [Full Text] [Related]
18. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study. Wu JS, James I, Wei Qiu, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG. Mult Scler; 2010 May 15; 16(5):526-32. PubMed ID: 20207784 [Abstract] [Full Text] [Related]
19. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, Varney MD, Taylor BV, Foote SJ, ANZgene Consortium, Kilpatrick TJ, Rubio JP. Tissue Antigens; 2009 Jul 15; 74(1):17-21. PubMed ID: 19392788 [Abstract] [Full Text] [Related]
20. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis. Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Torrabadella M, Azqueta C, Arbizu T. J Neurol Sci; 2010 Nov 15; 298(1-2):96-100. PubMed ID: 20810130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]